BAS/BSCR45 The mitochondrial permeability transition pore as a target for cardioprotection in ventricular cardiomyocytes harvested from patients with obstructive hypertrophic cardiomyopathy

Rees, P. S. C.; Davidson, S. M.; Harding, S. E.; Elliot, P. M.; Yellon, D. M.; Hausenloy, D. J.
September 2010
Heart;Sep2010, Vol. 96 Issue 17, pe26
Academic Journal
Rationale The opening of the mitochondrial permeability transition pore (mPTP) is a critical determinant of ischaemia-reperfusion injury, and preventing its opening confers powerful cardioprotection in non-diseased myocardium. Whether this cardioprotective effect is present in the setting of hypertrophic cardiomyopathy (HCM) is unknown and is investigated in this study. Methodology Local UCLH/UCL ethical committee approval had been granted for this study. Human adult ventricular cardiomyocytes were isolated from left ventricular septal tissue, harvested from consenting patients undergoing surgical myectomy for obstructive HCM. The cells were loaded with the fluorescent dye TMRM which localises to the mitochondria, generates oxidative stress within the mitochondria on confocal imaging, resulting in mPTP opening, as indicated by the collapse of the mitochondrial membrane potential. The time taken to induce the loss of mitochondrial membrane potential was used as a measure of mPTP opening sensitivity. Cells were randomised to the following: (1) DMSO 0.01% vehicle control (N=8/group); (2) cells pre-treated with ciclosporin-A (CsA)(0.2 α/4M) for 15 min (N=7/group); (3) cells pre-treated with atorvastatin (25 α/4M)(N=7/group). Results In the control group, mPTP opening was induced after 188.7%±22.7 s of oxidative stress, providing evidence for a functional mPTP in the setting of HCM. Furthermore, pretreatment with the known mPTP inhibitor, CsA, and atorvastatin, delayed the onset of mPTP opening by 51%±10% (p<0.001) and 35%±7% (p<0.05), respectively. Conclusions For the first time in diseased human ventricular myocytes, we have demonstrated that the mPTP is functional and that its opening can be inhibited by cardioprotective agents such as CsA and atorvastatin.


Related Articles

  • Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy. Flenner, Frederik; Friedrich, FelixW.; Ungeheuer, Nele; Christ, Torsten; Geertz, Birgit; Reischmann, Silke; Wagner, Stefan; Stathopoulou, Konstantina; Söhren, Klaus-Dieter; Weinberger, Florian; Schwedhelm, Edzard; Cuello, Friederike; Maier, Lars S.; Eschenhagen, Thomas; Carrier, Lucie // Cardiovascular Research;Jan2016, Vol. 109 Issue 1, p90 

    Aims Hypertrophic cardiomyopathy (HCM) is often accompanied by increased myofilament Ca2+ sensitivity and diastolic dysfunction. Recent findings indicate increased late Na+ current density in human HCM cardiomyocytes. Since ranolazine has the potential to decrease myofilament Ca2+ sensitivity...

  • Amniotic mesenchymal cells autotransplanted in a porcine model of cardiac ischemia do not differentiate to cardiogenic phenotypes. Sartore, Saverio; Lenzi, Maddalena; Angelini, Annalisa; Chiavegato, Angela; Gasparotto, Lisa; Coppi, Paolo De; Bianco, Roberto; Gerosa, Gino // European Journal of Cardio-Thoracic Surgery;Nov2005, Vol. 28 Issue 5, p677 

    Abstract: Objective: Transplantation of stem cells in the acute ischemic myocardium (AMI) may play a role in the recovery of cardiac function. Here, we investigated the ability of amniotic fluid-derived mesenchymal cells (AFC) for phenotypic conversion to vascular cells and cardiomyocytes (CM)...

  • BAS/BSCR15 The role of PINK1, a mitochondrial pro-survival kinase, in myocardial ischaemia-reperfusion. Siddall, H.; Sands, R.; Davidson, S. M.; Hausenloy, D. J.; Mocanu, M. M.; Yellon, D. M. // Heart;Sep2010, Vol. 96 Issue 17, pe16 

    PINK1, a kinase localised mainly in mitochondria, can protect neurons against oxidative damage and apoptosis by maintaining mitochondrial structure and function. Although PINK1 is highly expressed in the myocardium, there are no studies investigating the role of this kinase in the heart. We...

  • Hypertrophic cardiomyopathy: a heart in need of an energy bar? Vakrou, Styliani; Abraham, M. Roselle // Frontiers in Physiology;Aug2014, Vol. 5, p1 

    Hypertrophic cardiomyopathy (HCM) has been recently recognized as the most common inherited cardiovascular disorder, affecting 1 in 500 adults worldwide. HCM is characterized by myocyte hypertrophy resulting in thickening of the ventricular wall, myocyte disarray, interstitial and/or replacement...

  • Inhibition of sPLA2-IIA, C-reactive Protein or Complement: New Therapy for Patients with Acute Myocardial Infarction? Krijnen, Paul A. J.; Meischl, Christof; Nijmeijer, Remco; Visser, Cees A.; Hack, C. Erik; Niessen, Hans W. M. // Cardiovascular & Haematological Disorders - Drug Targets;Jun2006, Vol. 6 Issue 2, p111 

    Reperfusion of ischemic myocardium after acute myocardial infarction (AMI) induces a local activation of inflammatory reactions that results in ischemia/reperfusion (I/R)-injury. I/R-injury contributes considerably to the total cell damage in the heart after AMI. Secretory phospolipase A2-IIA...

  • The hypoxia-inducible factor pathway in adipocytes: the role of HIF-2 in adipose inflammation and hypertrophic cardiomyopathy. Qun Lin; ZhongYun // Frontiers in Endocrinology;Mar2015, Vol. 6, p1 

    Under obese conditions, adipose tissue can become oxygen-deficient or hypoxic. Extensive work has been done using various diet-induced obesity models to demonstrate an important role of hypoxia-induced signaling in adipose tissue and its impact on adipose functions related to adipogenesis,...

  • Pretreatment by Hyperoxia - A Tool to Reduce Ischaemia-Reperfusion Injury in the Myocardium. Karu, Inga; T�hep�ld, Peeter; Ruusalepp, Arno; Starkopf, Joel // Current Clinical Pharmacology;May2010, Vol. 5 Issue 2, p125 

    Atherosclerosis leads to narrowing and occlusion of coronary arteries, resulting in inadequate oxygen supply for maintenance of normal oxidative metabolism. To avoid profound ischaemia and subsequent necrosis of cardiomyocytes, blood flow has to be restored by means of thrombolysis, percutaneous...

  • The calcium paradox - What should we have to fear? de Oliveira, Marcos Aurélio Barboza; Brandi, Antônio Carlos; dos Santos, Carlos Alberto; Husseni Botelho, Paulo Henrique; Lasso Cortez, José Luís; Goissis, Gilberto; Braile, Domingo Marcolino // Brazilian Journal of Cardiovascular Surgery;2014, Vol. 29 Issue 2, p249 

    The calcium paradox was first mentioned in 1966 by Zimmerman et al. Thereafter gained great interest from the scientific community due to the fact of the absence of calcium ions in heart muscle cells produce damage similar to ischemiareperfusion. Although not all known mechanisms involved in...

  • Biologic Effect of Low-intensity Electromagnetic Radiation on Myocardium in Experimental Ischemia. Malinovskaya, S. L.; Bavrina, A. P.; Solovyova, T. I.; Rakhcheyeva, M. V.; Yakovleva, E. I.; Monich, V. A. // Medical Technologies in Medicine / Sovremennye Tehnologii v Medi;2015, Vol. 7 Issue 2, p49 

    The aim of the investigation was to study modification of lipid peroxidation level and myocardium microstructure in rats exposed to lowintensity laser radiation (LILR) as compared to the effects caused by broadband red light (BBRL). Materials and Methods. The research was performed on 91 white...


Read the Article


Sign out of this library

Other Topics